- Ophteis FR Pro is the ONLY OVD with sorbitol free radical scavenging.
- Ophteis FR Pro reduces cell death by an average of 27.8% when compared to market leading OVDs.*
- Ophteis FR Pro's bio-engineered composition of NaHA and sorbitol transforms the 2% NaHA dispersive solution into aviscous cohesive.
- A larger 1.2ml syringe gives you the confidence that Ophteis FR Pro will support all elements of your cataract procedure.
- Unlike many OVDs, Rayner’s Ophteis FR Pro does not need to be refrigerated before use. With its stable rheology at roomtemperature you will enjoy consistent performance for every procedure.
- FR Pro is designed to protect the endothelium, provide excellent chamber maintenance and is fully validated with all Rayner IOL injectors.
*University of Brighton, UK, in vitro chemical and phaco free radical studies, data to be published.
| Product | Ophteis FR Pro |
| NaHA Concentration | 20 mg/ml |
| Sorbitol Concentration | 40 mg/ml |
| NaHA origin | Biofermentation |
| Classification | Viscous cohesive |
| Syringe Volume | 1.2ml |
| Cannula Gauge | 27g |
| Average Molecular Weight | 1.8 Mda |
| Average Osmolarity | 325 mOsm/kg |
| PH | 6.8 to 7.4 |
| Storage | 2°C to 25°C |
| Product name | Ophteis FR Pro |
| Product Code | A-OPFR12 |
| Presentation | Sterile single-use syringe with 1.2ml 2.0% sodium hyaluronate solution, 4.0% sorbitol and single-use 27g injection cannula, Luer-Lock |
Not all products or offerings are approved or offered in every market and approved labelling and instructions may vary from one country to another. For country specific product information contact your local distributor or email iol_enquires@rayner.com.
This product is not approved by the FDA for use or distribution in the United States of America.
Rayner hold a selection of EC certificates for various products. Please contact the Regulatory Affairs team for the current version.
EYE CARE
IOLs
